TWD
HRMY icon

True Wealth Design’s Harmony Biosciences HRMY Stock Holding History

True Wealth Design’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.57K Buy
153
+35
+30% +$1.1K ﹤0.01% 1285
2026
Q1 		$3.31K Sell
118
-235
-67% -$7.71K ﹤0.01% 1366
2025
Q4 		$13.2K Buy
353
+282
+397% +$9.27K ﹤0.01% 756
2025
Q3 		$1.96K Buy
+71
New +$2.45K ﹤0.01% 1470
2025
Q2 		– Sell
-24
Closed -$797 – 2685
2025
Q1 		$797 Buy
24
+7
+41% +$251 ﹤0.01% 1352
2024
Q4 		$585 Sell
17
-40
-70% -$1.37K ﹤0.01% 1061
2024
Q3 		$2.28K Buy
+57
New +$2K ﹤0.01% 753

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

True Wealth Design's HRMY Position: Q2 2026 in Review

True Wealth Design increased its Harmony Biosciences (HRMY) stake by 30% in Q2 2026, buying an estimated $1.1K and bringing the position to 153 shares worth $5.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1285.

True Wealth Design first reported a position in HRMY in Q3 2024 and has held it in 7 quarters since. The position peaked at $13.2K in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • True Wealth Design held 153 shares of Harmony Biosciences worth $5.57K as of Q2 2026.
  • True Wealth Design bought 35 Harmony Biosciences shares in Q2 2026, an estimated $1.1K.
  • Harmony Biosciences made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1285 holding.
  • True Wealth Design first reported a position in Harmony Biosciences in Q3 2024 and has held it in 7 quarters since.
  • True Wealth Design's Harmony Biosciences position peaked at $13.2K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.